SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000338
Filing Date
2020-11-25
Accepted
2020-11-25 14:31:19
Documents
6
Period of Report
2020-11-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngio112520form8k.htm 8-K 152485
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 99714
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 20957
4 GRAPHIC image_002.gif GRAPHIC 26382
5 GRAPHIC image_003.gif GRAPHIC 17901
6 GRAPHIC image_001.gif GRAPHIC 4696
  Complete submission text file 0001607062-20-000338.txt   341682
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 (416) 364-2551
NUGENEREX IMMUNO-ONCOLOGY, INC. (Filer) CIK: 0001804585 (see all company filings)

IRS No.: 043208418 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-56153 | Film No.: 201349440
SIC: 2834 Pharmaceutical Preparations